Kocabaş Uğur, Duygu Hamza, Eren Nihan Kahya, Akyıldız Zehra İlke, Özyıldırım Serhan, Tülüce Selcen Yakar, Kırış Tuncay, Nazlı Cem
Cardiology Department, İzmir Atatürk Training and Research Hospital, 35360 Basın Sitesi, Izmir, Turkey.
Cardiology Department, Medical Faculty, Near East University, Nicosia, Cyprus.
Springerplus. 2016 Mar 22;5:356. doi: 10.1186/s40064-016-1987-x. eCollection 2016.
In recent years there has been an increase in clinical situations requiring lead extraction procedures of implanted cardiac devices. In our clinic, extraction procedures are performed with Evolution® mechanical lead extraction system. In this manuscript we aimed to evaluate our lead extraction procedures.
We retrospectively evaluated lead extraction procedures carried out on 41 patients [30 male, 11 female patient; mean age 61.5 ± 18.5 median 67 (23-85)] between 2008 and 2015 using Evolution® system. Procedural success, major and minor complications are determined according to previously published guidelines.
Mean duration of the lead implantation was 88.4 ± 62.5 months (6-240). Implanted device was a pacemaker in 27 (65.8 %) and ICD in 14 (34.2 %) of patients. Total 67 leads were extracted from the patients, 22 (32.8 %) were atrial, 30 (44.2 %) were ventricular, 14 (21.5 %) were dual coil defibrillator and 1 (1.5 %) was coronary sinus lead. Indications for lead removal were pacemaker decubitis and infection in 29 (70.8 %), lead dysfunction in 11 (26.8 %) and subclavian vein thrombosis in 1 (2.4 %) patient. Success rate with Evolution® system without using snare was 85.3 %. Clinical success rate was 97.5 % procedural success rate was 95.1 % and failure occured in one patient. Major complications occured in 2 (4.8 %) patients, 1 (2.4 %) was procedure related mortality. Minor complications were seen in 5 (12.2 %) of patients.
In our single center study it is shown that extraction of pacemaker and defibrillator leads of relatively long implantation duration and in an older age patient group may be successfully carried out using the Evolution® system. However due to potentially serious complications it is adviced to be done by experienced operators in centers with cardiovascular surgery backup.
近年来,需要对植入式心脏设备进行导线拔除术的临床情况有所增加。在我们的诊所,采用Evolution®机械导线拔除系统进行拔除手术。在本论文中,我们旨在评估我们的导线拔除手术。
我们回顾性评估了2008年至2015年间使用Evolution®系统对41例患者[30例男性,11例女性;平均年龄61.5±18.5岁,中位数67岁(23 - 85岁)]进行的导线拔除手术。根据先前发表的指南确定手术成功率、主要和次要并发症。
导线植入的平均持续时间为88.4±62.5个月(6 - 240个月)。27例(65.8%)患者植入的设备为起搏器,14例(34.2%)患者植入的是植入式心律转复除颤器(ICD)。共从患者体内拔除67根导线,其中22根(32.8%)为心房导线,30根(44.2%)为心室导线,14根(21.5%)为双线圈除颤器导线,1根(1.5%)为冠状窦导线。导线拔除的指征为起搏器褥疮和感染29例(70.8%),导线功能障碍11例(26.8%),锁骨下静脉血栓形成1例(2.4%)。未使用圈套器的Evolution®系统成功率为85.3%。临床成功率为97.5%,手术成功率为95.1%,1例患者手术失败。2例(4.8%)患者发生主要并发症,1例(2.4%)为与手术相关的死亡。5例(12.2%)患者出现次要并发症。
在我们的单中心研究中表明,对于植入时间相对较长且年龄较大的患者群体,使用Evolution®系统可以成功地拔除起搏器和除颤器导线。然而,由于可能出现严重并发症,建议由经验丰富的操作人员在有心血管外科支持的中心进行操作。